Butallylonal
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 5-sec-Butyl-5-(beta-bromoallyl)barbituric acid | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 1142-70-7 |
| ATC code | None |
| PubChem | CID 14362 |
| ChemSpider | 13723 |
| ChEMBL | CHEMBL469253 |
| Chemical data | |
| Formula | C11H15BrN2O3 |
| Mol. mass | 303.15 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Butallylonal is a barbiturate derivative invented in the 1920s.[1] It has sedative properties, and was used primarily as an anaesthetic in veterinary medicine.[2] Butallylonal is considered similar in effects to pentobarbital but is longer in action, being considered an intermediate-acting barbiturate rather than short-acting.
[edit] References
- ^ US 1739662
- ^ Mittmann U, Schmidt HD, Schmier J, Wirth RH (1976). "Hemorrhagic shock with fixed hypotension and with spontaneous recovery of blood pressure. A comparison of two shock models". Basic Research in Cardiology 71 (1): 47–59. doi:10.1007/BF01907782. PMID 1259685.
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |